These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 35069551)

  • 1. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
    Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
    Front Immunol; 2021; 12():780509. PubMed ID: 35069551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSRP1 Is a Prognostic Biomarker Correlated with CD8
    Luo G; Xu J; Xia Z; Liu S; Liu H; He K; Xiang G
    Biomed Res Int; 2021; 2021():9409836. PubMed ID: 33688504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
    Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
    Front Immunol; 2021; 12():612139. PubMed ID: 33679751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Wu M; Jiang L
    Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
    Chen W; Chen X; Li S; Ren B
    J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
    Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
    Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
    World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma.
    Huo J; Wu L; Zang Y
    BMC Med Genomics; 2021 Sep; 14(1):232. PubMed ID: 34544391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
    Zhang M; Pang HJ; Zhao W; Li YF; Yan LX; Dong ZY; He XF
    BMC Cancer; 2018 May; 18(1):511. PubMed ID: 29720116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
    Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
    Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD1
    Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
    J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
    Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
    Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
    Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
    Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mRNA Expression of
    Cui Z; Xiao L; Chen F; Wang J; Lin H; Li D; Wu Z
    Dis Markers; 2021; 2021():9971799. PubMed ID: 34457090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPDR1 correlates with immune cell infiltration in hepatocellular carcinoma and can be used as a prognostic biomarker.
    Chen R; Zhang Y
    J Cell Mol Med; 2020 Oct; 24(20):12107-12118. PubMed ID: 32935479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma.
    Liu Z; Liu L; Guo C; Yu S; Meng L; Zhou X; Han X
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108340. PubMed ID: 34789428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Kong W; Wu Z; Yang M; Zuo X; Yin G; Chen W
    IUBMB Life; 2020 Dec; 72(12):2672-2685. PubMed ID: 33211382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.